Notably, the density of CD39+CD103+ CD8+ T cells in the tumor nest is linked to improved survival and RFS, while the density of CD103SP CD8+ T cells is not, further implying that CD39+CD103+ CD8+ T cells are the main tumor cell killing population in situ. The gene discussed is ENTPD1; the disease is neoplasm.